• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. (ABBOTT) DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. (ABBOTT) DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE Back to Search Results
Model Number DBEC-125
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Diminished Pulse Pressure (2606); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/15/2023
Event Type  Death  
Manufacturer Narrative
The device history record for the reported oad could not be reviewed as the lot number was not provided.The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.H6 health effect - clinical code 4581: appropriate term / code not available: abrupt vessel closure, no reflow h6 investigation conclusion code 22: the diamondback 360 coronary orbital atherectomy system instructions for user manual states that abrupt vessel closure, no reflow, cardiac arrest, and death are potential adverse events that may occur and/or require intervention with use of the system.Csi id: (b)(6).
 
Event Description
A diamondback 360 coronary orbital atherectomy device (oad) was successfully used to treat a severely calcified lesion in the right coronary artery (rca).Stent placement was performed.Following treatment of the left anterior descending (lad) artery and two drug-eluting stent placements, angiographic imaging revealed the vessel shut down.The patient experienced no reflow, hemodynamic collapse, and pulseless electrical activity (pea) arrest.The patient was placed on extracorporeal membrane oxygenation (ecmo) and heart pump.Later in the evening the patient expired.In the opinion of the physician, the csi device caused or contributed to the vessel shutting down and patient's expiration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM
Type of Device
CORONARY ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC. (ABBOTT)
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC. (ABBOTT)
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer Contact
lalaine oria
1225 old hwy 8 nw
st. paul, MN 55112
MDR Report Key18477726
MDR Text Key332458986
Report Number3004742232-2024-00073
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberDBEC-125
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2023
Initial Date FDA Received01/09/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Death;
Patient Age87 YR
Patient SexMale
-
-